News from Eli Lilly

Follow

News from Eli Lilly

Stay current with all the latest and breaking news about Eli Lilly, compare headlines and perspectives between news sources on stories happening today. In total, 208 stories have been published about Eli Lilly which Ground News has aggregated in the past 3 months.

Follow

Stay current with all the latest and breaking news about Eli Lilly, compare headlines and perspectives between news sources on stories happening today. In total, 208 stories have been published about Eli Lilly which Ground News has aggregated in the past 3 months.

Covered Most By

Seeking Alpha

Lean Right

Quartz

Center

Benzinga

Center

CNBC

Center

Financial Times

Center

Seeking Alpha

Lean Right

Quartz

Center

Benzinga

Center

Suggest a source

Suggest a source

Looking for a source we don't already have? Suggest one here.

---

Top Eli Lilly News

Obesity · United States

Weight-loss drug linked to sleep apnea reduction: Research

82% Center coverage: 49 sources

The weight-loss drug Zepbound was linked to a reduction in obstructive sleep apnea (OSA), according to new research. Pharmaceutical manufacturer Eli Lilly on Wednesday said injections of its obesity drug tirzepatide — commonly known as Zepbound — “significantly reduced” the number of sleep apnea events during one’s sleep when compared to a placebo.See the Story

Europe · Belgium

No link between Ozempic, Wegovy and suicide, EU drug regulators say

66% Center coverage: 29 sources

Drug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal thoughts or actions. The European Medicines Agency regulatory committee announced the results of its review on Friday. It's the latest group to conclude there's no known tie between a new class of obesity drugs and suicide. See the Story

Donald Trump · United States

Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut

57% Center coverage: 21 sources

Rarely a day goes without President Joe Biden mentioning insulin prices. He promotes a $35 price cap for the medication for Americans on Medicare — in White House speeches, campaign stops and even at non-health care events around the country. His reelection team has flooded swing-state airwaves with ads mentioning it, in English and Spanish. All that would seemingly add up to a sweeping political and economic impact.See the Story

---

Latest News Stories

Microsoft · Germany

Location Germany: The Spatenstich-Republik

100% Left coverage: 1 sources

When corporations such as Microsoft and Eli Lilly invest in Germany, politicians take a leap of faith and pat themselves on the shoulders. Is this the turn for the site?See the Story

Eli Lilly · Hamburg

Wegovy, Mounjaro and Co.: Are the weight loss pills coming soon after the withdrawal injection?

100% Left coverage: 1 sources

Sprites from Novo Nordisk and Eli Lilly promise quick weight loss on prescription. The two pharmaceutical companies are booming, the industry wants to replicate diet pills soon. Many users, according to a doctor, discretion is important.See the Story

Eli Lilly · Milwaukee

Wisconsin pharmaceutical plant sold to pharma leader Eli Lilly Wisconsin family owned pharma plant sold to giant Eli Lily

100% Center coverage: 1 sources

The FDA-approved facility located in Pleasant Prairie is a leading sterile manufacturer in the pharmaceutical industry.See the Story

Eli Lilly · United States

Eli Lilly to acquire manufacturing facility from Nexus Pharma

100% Center coverage: 1 sources

(Reuters) – Eli Lilly said on Monday that it will acquire a manufacturing facility from Nexus Pharmaceuticals to produce injectable medicines. Lilly expects production at the facility based in Pleasant Prairie, Wisconsin, to begin at the end of 2025. WHY IT’S IMPORTANT Soaring demand for GLP-1 agonists, a class of highly effective diabetes and obesity drugs which suppress appetite and promote a feeling of fullness, has led to constrained sup…See the Story

Eli Lilly · Dallas

New weight-loss drug shows promise in treating sleep apnea, according to drugmaker

100% Right coverage: 1 sources

Eli Lilly announced last week that its latest weight-loss drug, Zepbound, may also benefit individuals with sleep apnea. The drugmaker has been running clinical trials testing the effectiveness of Zepbound, which the FDA approved to treat obesity in November, in treating a breathing disorder affecting an estimated 39 million Americans. A news release indicated that a phase-3 trial involving over 400 obese people with sleep apnea showed that taki…See the Story

Eli Lilly · Alzey

The pharmaceutical group Eli Lilly builds a new production site in Rhine-Palatinate

The US pharmaceutical group Eli Lilly will invest about EUR 2.3 billion in a new production site in Alzey in southeastern Rhine-Palatinate.See the Story

Eli Lilly · Germany

Removal prize as a health insurance benefit? Politicians consider it possible

For the insulin pens of manufacturers Novo Nordisk and Eli Lilly, a global hype has broken out. Patients in Germany still have to bear the costs for the medication themselves. However, health politicians see exceptions in the future also for statutory health insurance.See the Story

Eli Lilly · Paris

Anti-obesity drugs: Novo Nordisk and Eli Lilly switch to "made in France"

100% Left coverage: 1 sources

Although not marketed in France, their treatments will soon be produced there thanks to considerable investments.See the Story

Covered Most By

Seeking Alpha

Lean Right

Quartz

Center

Benzinga

Center

CNBC

Center

Financial Times

Center

Seeking Alpha

Lean Right

Quartz

Center

Benzinga

Center

Suggest a source

Looking for a source we don't already have? Suggest one here.

Media Bias Breakdown

How is the media covering Eli Lilly?

Eli Lilly often is covered by Center Media sources.

16%

Center: 70%

13%

Breaking News Topics Related to Eli Lilly

Marion County, Indiana

Indiana, United States

Nvidia

Germany

Indianapolis

United States

Stock Markets